Cargando…

A Deep Look Into COVID-19 Severity Through Dynamic Changes in Blood Cytokine Levels

An excessive inflammatory response to SARS-CoV-2 is thought to be a major cause of disease severity and mortality in patients with COVID-19. Longitudinal analysis of cytokine release can expand our understanding of the initial stages of disease development and help to identify early markers serving...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kleymenov, Denis A., Bykonia, Evgeniia N., Popova, Liubov I., Mazunina, Elena P., Gushchin, Vladimir A., Kolobukhina, Liudmila V., Burgasova, Olga A., Kruzhkova, Irina S., Kuznetsova, Nadezhda A., Shidlovskaya, Elena V., Divisenko, Elizaveta V., Pochtovyi, Andrei A., Bacalin, Valeria V., Smetanina, Svetlana V., Tkachuk, Artem P., Logunov, Denis Y., Gintsburg, Alexander L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8630739/ https://www.ncbi.nlm.nih.gov/pubmed/34858428 http://dx.doi.org/10.3389/fimmu.2021.771609

Ejemplares similares

Contamination of Hospital Surfaces with Bacterial Pathogens under the Current COVID-19 Outbreak
por: Pochtovyi, Andrei A., et al.
Publicado: (2021)

Revaccination in Age-Risk Groups with Sputnik V Is Immunologically Effective and Depends on the Initial Neutralizing SARS-CoV-2 IgG Antibodies Level
por: Godkov, Mikhail A., et al.
Publicado: (2022)

The Value of Rapid Antigen Tests for Identifying Carriers of Viable SARS-CoV-2
por: Shidlovskaya, Elena V., et al.
Publicado: (2021)

Safety and Immunogenicity of the GamTBvac, the Recombinant Subunit Tuberculosis Vaccine Candidate: A Phase II, Multi-Center, Double-Blind, Randomized, Placebo-Controlled Study
por: Tkachuk, Artem P., et al.
Publicado: (2020)

Avidity of IgG to SARS-CoV-2 RBD as a Prognostic Factor for the Severity of COVID-19 Reinfection
por: Manuylov, Victor, et al.
Publicado: (2022)

Dynamics of SARS-CoV-2 Major Genetic Lineages in Moscow in the Context of Vaccine Prophylaxis
por: Gushchin, Vladimir A., et al.
Publicado: (2022)

First-In-Human Trials of GamTBvac, a Recombinant Subunit Tuberculosis Vaccine Candidate: Safety and Immunogenicity Assessment
por: Vasina, Daria V., et al.
Publicado: (2019)

Single-domain antibody delivery using an mRNA platform protects against lethal doses of botulinum neurotoxin A
por: Panova, Eugenia A., et al.
Publicado: (2023)

Geographic and Temporal Variability of Hepatitis E Virus Circulation in the Russian Federation
por: Mikhailov, Mikhail I., et al.
Publicado: (2022)

Impact of Aerosol Dust on xMAP Multiplex Detection of Different Class Pathogens
por: Kleymenov, Denis A., et al.
Publicado: (2017)

Post-Vaccination and Post-Infection Immunity to the Hepatitis B Virus and Circulation of Immune-Escape Variants in the Russian Federation 20 Years after the Start of Mass Vaccination
por: Asadi Mobarkhan, Fedor A., et al.
Publicado: (2023)

Neutralizing Activity of Sera from Sputnik V-Vaccinated People against Variants of Concern (VOC: B.1.1.7, B.1.351, P.1, B.1.617.2, B.1.617.3) and Moscow Endemic SARS-CoV-2 Variants
por: Gushchin, Vladimir A., et al.
Publicado: (2021)

The rise and spread of the SARS-CoV-2 AY.122 lineage in Russia
por: Klink, Galya V., et al.
Publicado: (2021)

In Vitro Efficacy of Antivirals and Monoclonal Antibodies against SARS-CoV-2 Omicron Lineages XBB.1.9.1, XBB.1.9.3, XBB.1.5, XBB.1.16, XBB.2.4, BQ.1.1.45, CH.1.1, and CL.1
por: Pochtovyi, Andrei A., et al.
Publicado: (2023)

The rise and spread of the SARS-CoV-2 AY.122 lineage in Russia
por: Klink, Galya V, et al.
Publicado: (2022)

Sputnik V Effectiveness against Hospitalization with COVID-19 during Omicron Dominance
por: Shkoda, Andrey S., et al.
Publicado: (2022)

Antiviral Activity of N(1),N(3)-Disubstituted Uracil Derivatives against SARS-CoV-2 Variants of Concern
por: Siniavin, Andrei E., et al.
Publicado: (2022)

Development and characterization of chimera of yellow fever virus vaccine strain and Tick-Borne encephalitis virus
por: Kuznetsova, Nadezhda, et al.
Publicado: (2023)

Sputnik Light and Sputnik V Vaccination Is Effective at Protecting Medical Personnel from COVID-19 during the Period of Delta Variant Dominance
por: Sukhikh, Gennady T., et al.
Publicado: (2022)

Dynamic Changes in Hepatitis A Immunity in Regions with Different Vaccination Strategies and Different Vaccination Coverage
por: Kyuregyan, Karen K., et al.
Publicado: (2022)

Estimation of anti-orthopoxvirus immunity in Moscow residents and potential risks of spreading Monkeypox virus
por: Gushchin, Vladimir A., et al.
Publicado: (2022)

A Strategy for the Rapid Development of a Safe Vibrio cholerae Candidate Vaccine Strain
por: Karpov, Dmitry S., et al.
Publicado: (2021)

Current Trends of HIV Infection in the Russian Federation
por: Ogarkova, Daria, et al.
Publicado: (2023)

Microbiological Characteristics of Some Stations of Moscow Subway
por: Pochtovyi, Andrei A., et al.
Publicado: (2022)

Multi-subunit BCG booster vaccine GamTBvac: Assessment of immunogenicity and protective efficacy in murine and guinea pig TB models
por: Tkachuk, A. P., et al.
Publicado: (2017)

Virus-Vectored Ebola Vaccines
por: Dolzhikova, I.V., et al.
Publicado: (2017)

Sputnik V protection from COVID-19 in people living with HIV under antiretroviral therapy
por: Gushchin, Vladimir A., et al.
Publicado: (2022)

109 Problems and prospects of development of the subunit TB vaccine
por: Tkachuk, A.B., et al.
Publicado: (2014)

Broad Bactericidal Activity of the Myoviridae Bacteriophage Lysins LysAm24, LysECD7, and LysSi3 against Gram-Negative ESKAPE Pathogens
por: Antonova, Nataliia P., et al.
Publicado: (2019)

Improving nutrition for the prevention of gestational diabetes: Current status and perspectives
por: Popova, Polina V, et al.
Publicado: (2021)

NOD1/2 and the C-Type Lectin Receptors Dectin-1 and Mincle Synergistically Enhance Proinflammatory Reactions Both In Vitro and In Vivo
por: Tukhvatulin, Amir I, et al.
Publicado: (2020)

SARS-CoV-2 evolution in a patient with secondary B-cell immunodeficiency: A clinical case
por: Mukhina, Olgo A., et al.
Publicado: (2022)

SERS-Based Aptasensor for Rapid Quantitative Detection of SARS-CoV-2
por: Zavyalova, Elena, et al.
Publicado: (2021)

Cross-Reactive Fc-Fused Single-Domain Antibodies to Hemagglutinin Stem Region Protect Mice from Group 1 Influenza a Virus Infection
por: Voronina, Daria V., et al.
Publicado: (2022)

An open, non-randomised, phase 1/2 trial on the safety, tolerability, and immunogenicity of single-dose vaccine “Sputnik Light” for prevention of coronavirus infection in healthy adults
por: Tukhvatulin, Amir I., et al.
Publicado: (2021)

Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia
por: Logunov, Denis Y, et al.
Publicado: (2021)

Safety and immunogenicity of rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine against SARS-CoV-2 in healthy adolescents: an open-label, non-randomized, multicenter, phase 1/2, dose-escalation study
por: Tukhvatulin, Amir I., et al.
Publicado: (2023)

The Advantages and Challenges of Anticancer Dendritic Cell Vaccines and NK Cells in Adoptive Cell Immunotherapy
por: Abakushina, Elena V., et al.
Publicado: (2021)

Data discrepancies and substandard reporting of interim data of Sputnik V phase 3 trial – Authors' reply
por: Logunov, Denis Y, et al.
Publicado: (2021)

Chlamydial Type III Secretion System Needle Protein Induces Protective Immunity against Chlamydia muridarum Intravaginal Infection
por: Koroleva, Ekaterina A., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_dc3332lfkf92cs1u3cvfebaos1